Abstract

AbstractBackgroundViruses rely on the intracellular host machinery for replication, production of viral proteins and assembly. However, outside cells, as nanosized obligate intracellular pathogens, viruses share many biophysical properties with nanoparticles. Based on this biophysical equivalence, we hypothesized that viruses accumulate a host‐derived protein corona layer in extracellular environments similar to nanoparticles. Also, like nanoparticles, viruses should be able to function as nanosurface catalysts that enable accelerated amyloid protein aggregation extracellularly.MethodWe analyze the protein corona of respiratory syncytial virus (RSV) and herpes simplex virus 1 (HSV‐1) in different biological fluids including human plasma, human bronchoalveolar lavage fluid, non‐human primate plasma, and fetal bovine serum using proteomics, electron microscopy, infectivity and dendritic cell activation assays. In addition, we study the effect of RSV and HSV‐1 on the kinetics of amyloid aggregation of amylodogenic peptides such as amyloid‐beta (Aβ42) peptide, which is the major constituent of amyloid plaques in Alzheimer’s disease (AD) in‐vitro and in‐vivo in AD animal models.ResultWe show that RSV and HSV‐1 accumulate rich protein corona layers that are unique for each biological fluid. Moreover, we show that corona pre‐coating differentially affects viral infectivity and immune cell activation. Additionally, we demonstrate that viruses can bind amyloidogenic peptides in their corona and catalyze amyloid formation via surface‐assisted heterogeneous nucleation. Importantly, we show that HSV‐1, which has been implicated in AD, catalyzes the nucleation and accumulation of the Aβ42 peptide both in‐vitro and in‐vivo.ConclusionOur results provide a proof‐of‐concept for the presence of an extensive and dynamic viral protein corona layer that is critical for viral‐host interactions. Unlike the viral genome‐coded surface proteins, the viral protein corona is an acquired structural layer that is dependent on the viral microenvironment resulting in different viral identities based on the target tissue and the target organism. Additionally, the demonstration of corona‐driven heterogeneous nucleation of amyloids illustrates convergence between viral and amyloid pathologies suggesting a direct physical mechanistic link that warrants further investigation. Paper: https://www.nature.com/articles/s41467‐019‐10192‐2.

Highlights

  • Artificial nanoparticles accumulate a protein corona layer in biological fluids, which significantly influences their bioactivity

  • We assessed the respiratory syncytial virus (RSV) protein corona profiles in adult human plasma (HP), juvenile (6-month-old infants tested RSV negative at the time of sample collection) HP, human bronchoalveolar lavage fluid (BALF) from healthy adults, rhesus macaque plasma (MP), and fetal bovine serum (FBS). These biological fluids represent different microenvironments encountered by the virus in terms of tissue tropism (HP vs. BALF), zoonosis (MP), and culturing conditions (FBS)

  • The biological fluids were screened for antibodies against RSV using enzyme-linked immunosorbent assay (ELISA) and both adult HP and BALF contained high levels of anti-RSV IgG antibodies, unlike jHP, MP, and FBS (Supplementary Fig. 1)

Read more

Summary

Introduction

Artificial nanoparticles accumulate a protein corona layer in biological fluids, which significantly influences their bioactivity. As nanosized obligate intracellular parasites, viruses share many biophysical properties with artificial nanoparticles in extracellular environments and here we show that respiratory syncytial virus (RSV) and herpes simplex virus type 1 (HSV-1) accumulate a rich and distinctive protein corona in different biological fluids. We demonstrate that viruses bind amyloidogenic peptides in their corona and catalyze amyloid formation via surface-assisted heterogeneous nucleation. Nanoparticles have been shown to catalyze amyloid formation via binding of amyloidogenic peptides in their corona, thereby increasing local peptide concentration and inducing conformational changes that facilitate fibril growth via a heterogenous nucleation mechanism[7,8] This surface-assisted (heterogenous) nucleation has been demonstrated for several nanoparticles with different amyloidogenic peptides including IAPP and Aβ429,10.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call